Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 156584, 11 pages
http://dx.doi.org/10.1155/2015/156584
Research Article

High Intensity Interval Training Favourably Affects Angiotensinogen mRNA Expression and Markers of Cardiorenal Health in a Rat Model of Early-Stage Chronic Kidney Disease

1Clinical Biochemistry Laboratory, Central Queensland University, Building 81, Bruce Highway, Rockhampton, QLD 4702, Australia
2Human Exercise and Training Laboratory, Central Queensland University, Building 81, Bruce Highway, Rockhampton, QLD 4702, Australia

Received 29 January 2015; Accepted 3 April 2015

Academic Editor: Macaulay Onuigbo

Copyright © 2015 Patrick S. Tucker et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. AIHW, Ed., Australia's Health 2014, Australia's Health Series, Australian Institute of Health and Welfare (AIHW), Canberra, Australia, 2014.
  2. A. S. Go, G. M. Chertow, D. Fan, C. E. McCulloch, and C.-Y. Hsu, “Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization,” The New England Journal of Medicine, vol. 351, no. 13, pp. 1296–1370, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. U. D. Mathisen, T. Melsom, O. C. Ingebretsen et al., “Estimated GFR associates with cardiovascular risk factors independently of measured GFR,” Journal of the American Society of Nephrology, vol. 22, no. 5, pp. 927–937, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. D. M. Silverstein, “Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease,” Pediatric Nephrology, vol. 24, no. 8, pp. 1445–1452, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. P. S. Tucker, M. I. Kingsley, R. H. Morton, A. T. Scanlan, and V. J. Dalbo, “The increasing financial impact of chronic kidney disease in Australia,” International Journal of Nephrology, vol. 2014, Article ID 120537, 7 pages, 2014. View at Publisher · View at Google Scholar
  6. B. Stengel, M. E. Tarver-Carr, N. R. Powe, M. S. Eberhardt, and F. L. Brancati, “Lifestyle factors, obesity and the risk of chronic kidney disease,” Epidemiology, vol. 14, no. 4, pp. 479–487, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. R. T. Gansevoort, R. Correa-Rotter, B. R. Hemmelgarn et al., “Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention,” The Lancet, vol. 382, no. 9889, pp. 339–352, 2013. View at Publisher · View at Google Scholar
  8. M. M. H. Hermans, R. Henry, J. M. Dekker et al., “Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: the Hoorn study,” Journal of the American Society of Nephrology, vol. 18, no. 6, pp. 1942–1952, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. M. L. Ford, L. A. Tomlinson, T. P. E. Chapman, C. Rajkumar, and S. G. Holt, “Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4,” Hypertension, vol. 55, no. 5, pp. 1110–1115, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. D. E. Weiner, H. Tighiouart, P. C. Stark et al., “Kidney disease as a risk factor for recurrent cardiovascular disease and mortality,” American Journal of Kidney Diseases, vol. 44, no. 2, pp. 198–206, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. D. E. Weiner, H. Tighiouart, M. G. Amin et al., “Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies,” Journal of the American Society of Nephrology, vol. 15, no. 5, pp. 1307–1315, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. R. K. Soni, A. C. Porter, J. P. Lash, and M. L. Unruh, “Health-related quality of life in hypertension, chronic kidney disease, and coexistent chronic health conditions,” Advances in Chronic Kidney Disease, vol. 17, no. 4, pp. e17–e26, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Segura, C. Campo, P. Gil et al., “Development of chronic kidney disease and cardiovascular prognosis in essential hypertensive patients,” Journal of the American Society of Nephrology, vol. 15, no. 6, pp. 1616–1622, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Blacher, A. P. Guerin, B. Pannier, S. J. Marchais, M. E. Safar, and G. M. London, “Impact of aortic stiffness on survival in end-stage renal disease,” Circulation, vol. 99, no. 18, pp. 2434–2439, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. G. L. Bakris, E. Ritz, and World Kidney Day Steering Committee, “The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented,” The Journal of Clinical Hypertension (Greenwich), vol. 11, no. 3, pp. 144–147, 2009. View at Google Scholar
  16. J. L. Lavoie and C. D. Sigmund, “Minireview: overview of the renin-angiotensin system—an endocrine and paracrine system,” Endocrinology, vol. 144, no. 6, pp. 2179–2183, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Nguyen Dinh Cat and R. M. Touyz, “A new look at the renin-angiotensin system—focusing on the vascular system,” Peptides, vol. 32, no. 10, pp. 2141–2150, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. U. C. Brewster and M. A. Perazella, “The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease,” The American Journal of Medicine, vol. 116, no. 4, pp. 263–272, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Ciampone, R. Borges, I. P. De Lima, F. F. Mesquita, E. C. Cambiucci, and J. A. R. Gontijo, “Long-term exercise attenuates blood pressure responsiveness and modulates kidney angiotensin II signalling and urinary sodium excretion in SHR,” Journal of the Renin-Angiotensin-Aldosterone System, vol. 12, no. 4, pp. 394–403, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Agarwal, M. A. Welsch, J. N. Keller, and J. Francis, “Chronic exercise modulates RAS components and improves balance between pro- and anti-inflammatory cytokines in the brain of SHR,” Basic Research in Cardiology, vol. 106, no. 6, pp. 1069–1085, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. E. J. Howden, R. G. Fassett, N. M. Isbel, and J. S. Coombes, “Exercise training in chronic kidney disease patients,” Sports Medicine, vol. 42, no. 6, pp. 473–488, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Nielsen, A. Schmitz, M. Rehling, and C. E. Mogensen, “Systolic blood pressure relates to the rate of decline of glomerular filtration rate in type II diabetes,” Diabetes Care, vol. 16, no. 11, pp. 1427–1432, 1993. View at Publisher · View at Google Scholar · View at Scopus
  23. A. E. Tjønna, I. M. Leinan, A. T. Bartnes et al., “Low- and high-volume of intensive endurance training significantly improves maximal oxygen uptake after 10-weeks of training in healthy men,” PLoS ONE, vol. 8, no. 5, Article ID e65382, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Moholdt, E. Madssen, Ø. Rognmo, and I. L. Aamot, “The higher the better? Interval training intensity in coronary heart disease,” Journal of Science and Medicine in Sport, vol. 17, no. 5, pp. 506–510, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. H. E. Molmen-Hansen, T. Stolen, A. E. Tjonna et al., “Aerobic interval training reduces blood pressure and improves myocardial function in hypertensive patients,” European Journal of Preventive Cardiology, vol. 19, no. 2, pp. 151–160, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Moholdt, I. L. Aamot, I. Granøien et al., “Aerobic interval training increases peak oxygen uptake more than usual care exercise training in myocardial infarction patients: a randomized controlled study,” Clinical Rehabilitation, vol. 26, no. 1, pp. 33–44, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. E. J. Howden, J. S. Coombes, H. Strand, B. Douglas, K. L. Campbell, and N. M. Isbel, “Exercise training in CKD: efficacy, adherence, and safety,” American Journal of Kidney Diseases, vol. 65, no. 4, pp. 583–591, 2015. View at Publisher · View at Google Scholar
  28. A. C. King, W. L. Haskell, D. R. Young, R. K. Oka, and M. L. Stefanick, “Long-term effects of varying intensities and formats of physical activity on participation rates, fitness, and lipoproteins in men and women aged 50 to 65 years,” Circulation, vol. 91, no. 10, pp. 2596–2604, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. G. A. Brooks and T. P. White, “Determination of metabolic and heart rate responses of rats to treadmill exercise,” Journal of Applied Physiology Respiratory Environmental and Exercise Physiology, vol. 45, no. 6, pp. 1009–1015, 1978. View at Google Scholar · View at Scopus
  30. Y. Yu, J. C. Fuscoe, C. Zhao et al., “A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages,” Nature Communications, vol. 5, article 3230, 2014. View at Publisher · View at Google Scholar
  31. F. Z. Marques, A. E. Campain, M. Tomaszewski et al., “Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs,” Hypertension, vol. 58, no. 6, pp. 1093–1098, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Friedlander, J. D. Kark, S. Eisenberg, and Y. Stein, “Calculation of LDL-cholesterol from total cholesterol, triglyceride and HDL-cholesterol: a comparison of methods in the Jerusalem Lipid Research Clinic Prevalence Study,” Israel Journal of Medical Sciences, vol. 18, no. 12, pp. 1242–1252, 1982. View at Google Scholar · View at Scopus
  34. K. D. Marcus and C. M. Tipton, “Exercise training and its effects with renal hypertensive rats,” Journal of Applied Physiology, vol. 59, no. 5, pp. 1410–1415, 1985. View at Google Scholar · View at Scopus
  35. K. Kitada, H. Kobori, and A. Nishiyama, “Liver-specific angiotensinogen suppression: an old yet novel target for blood pressure control through RAS inhibition?” Hypertension Research, vol. 37, no. 5, pp. 393–394, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Gardes, J. Bouhnik, E. Clauser, P. Corvol, and J. Menard, “Role of angiotensinogen in blood pressure homeostasis,” Hypertension, vol. 4, no. 2, pp. 185–189, 1982. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Tanimoto, F. Sugiyama, Y. Goto et al., “Angiotensinogen-deficient mice with hypotension,” The Journal of Biological Chemistry, vol. 269, no. 50, pp. 31334–31337, 1994. View at Google Scholar · View at Scopus
  38. S. Kimura, J. J. Mullins, B. Bunnemann et al., “High blood pressure in transgenic mice carrying the rat angiotensinogen gene,” The EMBO Journal, vol. 11, no. 3, pp. 821–827, 1992. View at Google Scholar
  39. J. Menard, A.-I. K. El Amrani, F. Savoie, J. Bouhnik, K. R. Lynch, and M. J. Peach, “Angiotensinogen: an attractive and underrated participant in hypertension and inflammation,” Hypertension, vol. 18, no. 5, pp. 705–707, 1991. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Agrawal, S. Agarwal, and S. Naik, “Genetic contribution and associated pathophysiology in end-stage renal disease,” The Application of Clinical Genetics, vol. 3, pp. 65–84, 2010. View at Google Scholar
  41. W.-C. Cheng, W.-Y. Shu, C.-Y. Li et al., “Intra- and inter-individual variance of gene expression in clinical studies,” PLoS ONE, vol. 7, no. 6, Article ID e38650, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Whitehead and D. L. Crawford, “Variation in tissue-specific gene expression among natural populations,” Genome Biology, vol. 6, no. 2, article R13, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. A. L. Oberg, B. M. Bot, D. E. Grill, G. A. Poland, and T. M. Therneau, “Technical and biological variance structure in mRNA-Seq data: life in the real world,” BMC Genomics, vol. 13, no. 1, article 304, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Agarwal, C. M. Elks, S. D. Reed, N. Mariappan, D. S. A. Majid, and J. Francis, “Chronic exercise preserves renal structure and hemodynamics in spontaneously hypertensive rats,” Antioxidants & Redox Signaling, vol. 16, no. 2, pp. 139–152, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Zamboli, L. De Nicola, R. Minutolo, V. Bertino, F. Catapano, and G. Conte, “Management of hypertension in chronic kidney disease,” Current Hypertension Reports, vol. 8, no. 6, pp. 497–501, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. G. Remuzzi, N. Perico, M. Macia, and P. Ruggenenti, “The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease,” Kidney International, vol. 68, no. 99, pp. S57–S65, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. N. Ouerghi, M. Feki, N. Kaabachi, M. Khammassi, S. Boukorraa, and A. Bouassida, “Effects of a high-intensity intermittent training program on aerobic capacity and lipid profile in trained subjects,” Open Access Journal of Sports Medicine, vol. 5, pp. 243–248, 2014. View at Publisher · View at Google Scholar
  48. A. Paoli, Q. F. Pacelli, T. Moro et al., “Effects of high-intensity circuit training, low-intensity circuit training and endurance training on blood pressure and lipoproteins in middle-aged overweight men,” Lipids in Health and Disease, vol. 12, no. 1, article 131, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Racil, O. Ben Ounis, O. Hammouda et al., “Effects of high vs. Moderate exercise intensity during interval training on lipids and adiponectin levels in obese young females,” European Journal of Applied Physiology, vol. 113, no. 10, pp. 2531–2540, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. H. S. Kessler, S. B. Sisson, and K. R. Short, “The potential for high-intensity interval training to reduce cardiometabolic disease risk,” Sports Medicine, vol. 42, no. 6, pp. 489–509, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Poss, F. Custodis, C. Werner, O. Weingartner, M. Bohm, and U. Laufs, “Cardiovascular disease and dyslipidemia: beyond LDL,” Current Pharmaceutical Design, vol. 17, no. 9, pp. 861–870, 2011. View at Publisher · View at Google Scholar
  52. J. R. Burnett, “Lipids, lipoproteins, atherosclerosis and cardiovascular disease,” The Clinical Biochemist Reviews, vol. 25, no. 1, p. 2, 2004. View at Google Scholar
  53. G. Piecha, M. Adamczak, and E. Ritz, “Dyslipidemia in chronic kidney disease: pathogenesis and intervention,” Polskie Archiwum Medycyny Wewnetrznej, vol. 119, no. 7-8, pp. 487–492, 2009. View at Google Scholar · View at Scopus
  54. N. A. Smart, A. D. Williams, I. Levinger et al., “Exercise & Sports Science Australia (ESSA) position statement on exercise and chronic kidney disease,” Journal of Science and Medicine in Sport, vol. 16, no. 5, pp. 406–411, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. S.-J. Pinto-Sietsma, W. M. T. Janssen, H. L. Hillege, G. Navis, D. de Zeeuw, and P. E. de Jong, “Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population,” Journal of the American Society of Nephrology, vol. 11, no. 10, pp. 1882–1888, 2000. View at Google Scholar · View at Scopus
  56. N. R. Shah and F. Dumler, “Hypoalbuminaemia—a marker of cardiovascular disease in patients with chronic kidney disease stages II-IV,” International Journal of Medical Sciences, vol. 5, no. 6, pp. 366–370, 2008. View at Google Scholar · View at Scopus
  57. N. E. Straznicky, M. T. Grima, E. A. Lambert et al., “Exercise augments weight loss induced improvement in renal function in obese metabolic syndrome individuals,” Journal of Hypertension, vol. 29, no. 3, pp. 553–564, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. R. D. Manning Jr., N. Tian, and S. Meng, “Oxidative stress and antioxidant treatment in hypertension and the associated renal damage,” American Journal of Nephrology, vol. 25, no. 4, pp. 311–317, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. G. Keller, G. Zimmer, G. Mall, E. Ritz, and K. Amann, “Nephron number in patients with primary hypertension,” The New England Journal of Medicine, vol. 348, no. 2, pp. 101–108, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Floege, M. W. Burns, C. E. Alpers et al., “Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model,” Kidney International, vol. 41, no. 2, pp. 297–309, 1992. View at Publisher · View at Google Scholar · View at Scopus